Rimantadine was approved by the FDA to treat influenza A
In 1994, Rimantadine, derived from amantadine, was approved by the Food and Drug Administration (FDA) to treat influenza…
Biotechnology | Diagnostics | Disease | FDA | Neurology | Ophthalmogy
Omeros Corp was founded
In 1994, Omeros Corp. was founded in Seattle as a biopharmaceutical company committed to discovering, developing and commercializing…
Bristol-Myers Squibb’s PRAVACHOL (pravastatin sodium) granted expanded usage from the FDA
In 1994, Bristol-Myers Squibb’s PRAVACHOL (pravastatin sodium) was granted expanded usage from the U.S. Food and Drug Administration…
Biotechnology | Disease | FDA | Medicine
Genentech drug Pulmozyme (dornase alfa) was approved by the FDA
On Dec. 30, 1993, the Genentech drug Pulmozyme (dornase alfa) was approved by the U.S. Food and Drug…
Biotechnology | FDA | Medicine | Therapeutics
FDA approved Risperidone for use as atypical antipsychotic medication
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
Genentech drug Nutropin was approved
On Nov. 17, 1993, Genentech drug Nutropin was approved by the U.S. Food and Drug Administration (FDA) for…
FDA granted approval for the sale of the Ahmed Glaucoma Valve
On Nov. 12 ,1993, FDA granted approval for the sale of the Ahmed Glaucoma Valve designed and manufactured…
Biotechnology | Disease | FDA | Therapeutics
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Bayer’s Betaseron, the first of several…
Clinical Research | Disease | FDA | IRB | Medicine | Oncology | Therapeutics | Women's Health
FDA issued guidelines calling for improved assessments of medication responses as a function of gender
On Jul. 22, 1993, revising a policy from 1977 that excluded women of childbearing potential from early drug…
Biotechnology | Chemistry | Disease | FDA | Therapeutics
The Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established
On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
The FDA approved use of a new haemophilus b conjugate vaccine for infants and children
On Mar. 30, 1993, the U.S. Food and Drug Administration (FDA) approved a new Haemophilus b conjugate vaccine,…
Agriculture | Biotechnology | FDA | U.S. Congress | USDA
FDA declared genetically-engineered foods are not inherently dangerous and do not require special regulation
In 1993, the U.S. Food and Drug Administration (FDA) declared genetically-engineered foods are not inherently dangerous and do…
FDA added new CBER reviewers to streamline biologics review and user fees were enacted
In 1993, The U.S. Food and Drug Administration (FDA) added new CBER reviewers to streamline biologics review. User…
Biotechnology | Disease | FDA | Forestry | Oncology | Therapeutics | Women's Health
Taxol (paclitaxel) approved by the FDA for the treatment of ovarian cancer that has failed other therapy
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
Biotechnology | FDA | Infectious Disease | Therapeutics | Vaccine | WHO
Japanese encephalitis virus vaccine inactivated was licensed
On Dec. 10, 1992, the Japanese encephalitis (JE) virus vaccine inactivated (JE-Vax by Research Foundation for Microbial Diseases…
Diagnostics | FDA | NIH | Oncology | Radiology | U.S. Congress | Women's Health
The Mammography Quality Standards Act was passed by the US Congress
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress…
PathoGenesis was founded
On Sept. 3, 1992, PathoGenesis Corp. was founded by Robert Nowinski. The company, based in Seattle, developed an…
Agriculture | Biotechnology | FDA | USDA
FDA announced new food labeling rules
On Feb. 29, 1992, the U.S. Food and Drug Administration (FDA) announced new food labeling rules. The purpose…
Prescription Drug User Fee Act required drug and biologics manufacturers to pay fees for product applications, and other services
In 1992, President George Bush signed the Prescription Drug User Fee Act (PDUFA) and under the Clinton administration,…
University of Iowa Research Foundation received U.S. patents for CMV promoter
In 1992, the University of Iowa (UI) Research Foundation received its first U.S. patent on the CMV promoter,…
Diphtheria and tetanus toxoids and acellular pertussis vaccine was licensed for use
On Dec. 17, 1991, the Diphtheria and tetanus toxoids and acellular pertussis vaccine (Acel-Imune by Lederle) was licensed…
Biotechnology | Disease | FDA | HIV
Bristol-Myers’ VIDEX (didanosine) was approved by the US Food and Drug Administration
On Oct. 9, 1991, Bristol-Myers’ VIDEX (didanosine) was approved by the U.S. Food and Drug Administration for the…
Cellpro announced its initial public offering
On Aug. 26, 1991, Cellpro announced its initial public offering. CellPro, founded in Bothell, Washington, developed the CEPRATE…
ICOS Corporation completed its IPO
On Jun. 6, 1991, ICOS completed its IPO at at $8.00 per share for a total of $36…
Immunex received FDA approval to market Leukine (GM-CSF) in the U.S.
In March 1991, Immunex announced it had received U.S. Food and Drug Administration (FDA) approval to market Leukine…
FDA approved White blood cell colony-stimulating factors (G-CSF and GM-CSF)
On Feb. 22, 1991, the Food and Drug Administration (FDA) announced that it had approved Amgen’s two white…
Biotechnology | FDA | NIH | Therapeutics | U.S. Congress
The policy for protection of human subjects in research was adopted by more than a dozen federal entities
In 1991, the policy for protection of human subjects in research, promulgated in 1981 by the U.S. Food…
Biotechnology | Disease | FDA | Therapeutics
Regulations published to Accelerate the Review of Drugs for life-threatening diseases
In 1991, the U.S. Food and Drug Administration (FDA) published regulations to Accelerate the Review of Drugs for life-threatening diseases….
Biotechnology | FDA | Medicine | Therapeutics
Bristol-Myers’ cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) approved by the US Food and Drug Administration
In 1991, Bristol Myers Squibb’s cardiovascular medicines, PRAVACHOL (pravastin sodium) and MONOPRIL (fosinopril sodium) were approved by the…